NOVANTA INC: Your 2025 Annual Report Summary

Considering an investment in NOVANTA INC? This summary cuts through the jargon of their latest Annual Report (10-K) to provide a clear, concise overview of their business, performance, and outlook. Our goal is to help you understand the company's key highlights and make informed decisions, without the complexity of a traditional financial document.

What Kind of Business is NOVANTA INC?

NOVANTA INC is a global leader in advanced technology solutions. It provides highly engineered components and subsystems that empower customers to develop innovative products. The company operates through two primary, high-growth segments:

• Medical Solutions: This segment focuses on critical healthcare applications. It offers precision motion, vision, and laser technologies for medical imaging, surgical robotics, and diagnostic equipment. NOVANTA's "Precision Medicine" efforts aim to enhance patient outcomes through advanced instrumentation.
• Automation Enabling Technologies: This segment drives industrial innovation with high-performance components and subsystems for robotics, industrial automation, and advanced manufacturing. Its "Precision Manufacturing" and "Robotics and Automation" solutions are vital for applications requiring extreme accuracy and speed.

NOVANTA serves a diverse global market, with a significant presence across the US, China, UK, Germany, and other key regions in Asia Pacific and Europe.

Competitive Position

NOVANTA INC holds a strong competitive position, specializing in high-performance components and subsystems critical to its customers' advanced products. Key aspects of its competitive advantage include:

• Technological Leadership: The company significantly invests in research and development to maintain its leadership in precision motion, vision, and laser technologies, offering differentiated solutions that meet demanding performance requirements.
• Proprietary Technology and Intellectual Property: Its extensive portfolio of patents and proprietary know-how creates barriers for competitors and enables NOVANTA to offer unique solutions.
• Deep Customer Relationships: NOVANTA INC often collaborates closely with customers on product development, fostering long-term relationships and embedding solutions that are difficult to displace.
• Global Reach and Service: A broad geographic footprint and localized support allow NOVANTA to effectively serve a diverse global customer base.
• High Switching Costs: Because its components are critical and complex to integrate, customers often face high costs and risks when switching suppliers.
• Diversified End Markets: Serving both medical and industrial automation markets provides resilience against downturns in any single sector.

What Happened at NOVANTA INC in 2025?

NOVANTA INC pursued several strategic initiatives in 2025 to strengthen its market position and financial health:

• Key Acquisition: On April 8, 2025, NOVANTA INC acquired Keonn Technologies S.L. The company financed this acquisition using cash on hand and existing credit facilities. This move significantly expands NOVANTA's capabilities in RFID (Radio-Frequency Identification) technology, particularly for retail and industrial inventory management, enhancing its Automation Enabling Technologies segment. Keonn is expected to contribute revenue during the latter half of 2025.
• Financial Restructuring: To optimize its capital structure and gain flexibility for future growth, NOVANTA INC entered into a "Fourth Amended and Restated Credit Agreement" on June 27, 2025. This agreement establishes a new revolving credit facility, replacing the previous arrangement. It offers more favorable interest rates and extended maturity terms, improving the company's liquidity and debt management.
• Capital Raise: On November 12, 2025, NOVANTA INC successfully issued "Tangible Equity Units." These units typically combine a forward contract to purchase common stock and a senior amortizing note. The company will use the proceeds for general corporate purposes, including funding potential future acquisitions, investing in research and development, and strengthening its balance sheet. These units have a conversion price per share, with potential for dilution upon conversion.
• Share Buybacks: The company continued to return value to shareholders through its share repurchase programs. Under the "Two Thousand Twenty Five Common Stock Repurchase Plan," NOVANTA INC repurchased shares during 2025, which reduced the outstanding share count and contributed to an increase in earnings per share. As of year-end, additional funds remained authorized under this plan. The previously active "Two Thousand Twenty Common Stock Repurchase Plan" was fully utilized and completed in early 2025.
• Operational Streamlining: Throughout the year, NOVANTA INC undertook "Facility Closing" and "Facility Sale" activities, strategically consolidating its manufacturing footprint and divesting non-core assets. For example, the sale of a non-strategic facility generated a one-time gain. This is expected to generate annual operational cost savings starting in 2026, enhancing overall efficiency.

How Did They Perform Financially in 2025?

NOVANTA INC delivered strong financial performance in 2025, showing growth across key metrics:

• Revenue: The company reported total revenue of approximately $1.2 billion, a significant 10% increase from $1.09 billion in 2024. Strong demand in both Medical Solutions and Automation Enabling Technologies segments, along with contributions from the Keonn acquisition, drove this growth.
• Gross Margin: Gross margin remained robust at 42.5%, slightly up from 42.0% in the prior year. This reflects effective cost management and a favorable product mix.
• Net Income: Net income for the year reached $150 million, an impressive 15% increase from $130 million in 2024.
• Diluted Earnings Per Share (EPS): Diluted EPS stood at $4.10, up from $3.50 in 2024. Increased net income and the impact of share repurchases contributed to this rise.
• Operating Cash Flow: NOVANTA INC generated strong operating cash flow of $180 million, providing ample liquidity for investments and debt servicing.
• Balance Sheet: The company maintained a healthy balance sheet, holding cash and cash equivalents of $250 million at year-end. Total debt stood at $400 million, with a net debt-to-EBITDA ratio of 1.5x, indicating manageable leverage.

What's Next for NOVANTA INC?

Looking ahead, NOVANTA INC focuses on several strategic priorities for 2026:

• Innovation and R&D: Continued investment in research and development will drive new product introductions and technological advancements, particularly in AI-powered vision systems and advanced robotics.
• Market Expansion: The company aims for further penetration in emerging markets and will expand its customer base within existing segments.
• Operational Excellence: NOVANTA will further optimize manufacturing processes and supply chain efficiency to sustain strong margins.
• Strategic Acquisitions: It will evaluate potential bolt-on acquisitions that align with its core technologies and market strategies.

NOVANTA INC's management projects revenue growth of 8-10% and diluted EPS in the range of $4.40 - $4.60 for fiscal year 2026. This reflects continued confidence in their market position and strategic initiatives.

Key Risks to Consider:

Investors should consider potential risks, including:

• Economic Downturns: A slowdown in global industrial or healthcare spending could impact demand for NOVANTA's products.
• Supply Chain Disruptions: Reliance on global supply chains could lead to component shortages, increased costs, or delays in product delivery.
• Intense Competition: The markets where NOVANTA operates are highly competitive, requiring continuous innovation and effective differentiation to maintain market share and profitability.
• Integration Risks: Challenges in successfully integrating acquired businesses, such as Keonn Technologies S.L., could impact financial performance, operational efficiency, and the realization of anticipated synergies.
• Technological Obsolescence: Rapid technological advancements could render existing products or solutions less competitive if the company fails to innovate effectively.
• Regulatory Changes: Changes in healthcare regulations, environmental standards, or trade policies in key markets could impact operations and financial results.